Philips unveiled the Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
BioCardia Inc., a cardiovascular regenerative medicine company, announced positive 12-month results for the randomized Transendocardial Autologous Cells (MSC or BMC) in Ischemic Heart Failure Trial (TAC-HFT).
Thomas Jefferson University researchers discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a new understanding of the effects of race on heart disease.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
TherOx Inc. released results from the company's multicenter Investigational Device Exemption (IDE) pilot study that showed a 9.6 percent infarct size at 30 days in high-risk patients treated with its next-generation system for Supersaturated Oxygen (SSO2) Therapy. This therapy is intended to provide interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart muscle in heart attack patients. The study results were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Toshiba introduced its Adaptive Diagnostics computed tomography (CT) technology, which simplifies complex exams, lowers dose and improves diagnostic accuracy and reproducibility, at the Radiological Society of North America Annual Meeting (RSNA 2013).
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman Left Atrial Appendage Closure (LAA) device outweigh the risks. The company expects a decision from the FDA in the first half of 2014.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Novarad’s NovaCardio electrocardiogram (ECG) integrates with cardiology picture archiving and communication system (PACS)/cardiovascular information system (CVIS) to enable digital ECG reading, annotation, manipulation, storage and easy reporting. NovaCardio ECG was debuted at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
The National Cheng Kung University Heart Science and Medical Devices Research Center (NCKU HSDMRC) and the Division of Cardiothoracic Surgery, Department of Surgery, Duke University, Durham, NC, USA, jointly carried out a cardiac assist device implantation on a calf in October.
AccessClosure Inc. announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning its U.S. Patent No. 7,008,439 (the “Janzen ’439 patent"), covering technologies to close holes in arteries.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and an abnormal stress test, treatment of their narrowed arteries by the common procedure of angioplasty may not provide additional benefits compared to drug therapy alone.
The U.S. Centers for Medicare & Medicaid Services (CMS) finalized updates to payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule (MPFS) on or after Jan. 1, 2014.
Hear why Siemens SOMATOM Definition Edge is the CT your emergency department (ED) has been dreaming about from the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The human body begins to adapt to microgravity of low Earth orbit shortly after launch, according to surgeon astronaut Lee Morin, M.D., Ph.D., and astronaut mission specialist, NASA Johnson Space Center, Houston. Morin visited the International Space Station in 2002 as part of the STS-110 Atlantis space shuttle crew.
Interventional cardiologists at Mount Sinai Hospital are the first in the world to use a newly U.S. Food and Drug Administration (FDA)-approved device for the treatment of severely calcified coronary arteries before the placement of a cardiac stent to open a blocked artery.
Medtronic Inc. announced the first-in-human implant of the world’s smallest pacemaker: the Micra Transcatheter Pacing System (TPS). The device was implanted in a patient in Linz, Austria as part of the Medtronic global pivotal clinical trial.